USD 0.87
(8.75%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 | 817 Thousand USD | 0.0% |
2023 | 1.18 Million USD | 2878.12% |
2022 | 39.95 Thousand USD | -78.33% |
2021 | 184.35 Thousand USD | 3.14% |
2020 | 178.73 Thousand USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 FY | 817 Thousand USD | -31.34% |
2024 Q3 | 915 Thousand USD | 0.0% |
2024 Q1 | 1.1 Million USD | 0.0% |
2024 Q2 | 1 Million USD | 0.0% |
2024 Q4 | 817 Thousand USD | 0.0% |
2023 FY | 1.18 Million USD | 2878.12% |
2023 Q2 | - USD | 0.0% |
2023 Q1 | - USD | -100.0% |
2023 Q4 | 1.18 Million USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2022 Q4 | 39.95 Thousand USD | -48.25% |
2022 FY | 39.95 Thousand USD | -78.33% |
2022 Q3 | 77.21 Thousand USD | -32.22% |
2022 Q2 | 113.9 Thousand USD | -23.86% |
2022 Q1 | 149.61 Thousand USD | -18.84% |
2021 Q2 | 558.7 Thousand USD | -10.56% |
2021 FY | 184.35 Thousand USD | 3.14% |
2021 Q4 | 184.35 Thousand USD | -60.89% |
2021 Q3 | 471.42 Thousand USD | -15.62% |
2021 Q1 | 624.63 Thousand USD | 249.47% |
2020 Q4 | 178.73 Thousand USD | 0.0% |
2020 FY | 178.73 Thousand USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2004 FY | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Envoy Medical, Inc. | 404 Thousand USD | -102.228% |
OrthoPediatrics Corp. | 13.45 Million USD | 93.93% |
Lucid Diagnostics Inc. | 199 Thousand USD | -310.553% |
Nano-X Imaging Ltd. | 4.04 Million USD | 79.802% |
Nexalin Technology, Inc. | - USD | -Infinity% |
PAVmed Inc | 2.96 Million USD | 72.399% |
Accelerate Diagnostics, Inc. | 36.1 Million USD | 97.737% |
Rapid Micro Biosystems, Inc. | 6.21 Million USD | 86.852% |
RxSight, Inc. | 1.21 Million USD | 32.535% |
Sight Sciences, Inc. | 31.7 Million USD | 97.423% |
SI-BONE, Inc. | 36.06 Million USD | 97.735% |
TELA Bio, Inc. | 40.51 Million USD | 97.983% |
Treace Medical Concepts, Inc. | 53 Million USD | 98.459% |
Bioventus Inc. | 366.99 Million USD | 99.777% |
BrainsWay Ltd. | 239 Thousand USD | -241.841% |
Vivos Therapeutics, Inc. | 1.52 Million USD | 46.285% |
CVRx, Inc. | 30.38 Million USD | 97.311% |
electroCore, Inc. | 537 Thousand USD | -52.142% |
Helius Medical Technologies, Inc. | 12 Thousand USD | -6708.333% |
Inogen, Inc. | 18.27 Million USD | 95.528% |
IceCure Medical Ltd | 376 Thousand USD | -117.287% |
Spectral AI, Inc. | - USD | -Infinity% |
Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -124.621% |
MaxCyte, Inc. | 17.96 Million USD | 95.453% |
Acutus Medical, Inc. | 32.65 Million USD | 97.498% |
PetVivo Holdings, Inc. | 1.01 Million USD | 19.66% |
Talis Biomedical Corporation | 16.78 Million USD | 95.133% |
NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -1377.824% |
Orthofix Medical Inc. | 93.1 Million USD | 99.123% |
DIH Holding US, Inc. Warrants | - USD | -Infinity% |
Cerus Corporation | 59.79 Million USD | 98.634% |
Venus Concept Inc. | 70.79 Million USD | 98.846% |
TriSalus Life Sciences, Inc. | 1.24 Million USD | 34.325% |
LivaNova PLC | 568.54 Million USD | 99.856% |
908 Devices Inc. | 3.92 Million USD | 79.206% |
Alphatec Holdings, Inc. | 511.03 Million USD | 99.84% |
Nemaura Medical Inc. | 3.08 Million USD | 73.54% |
NeuroPace, Inc. | 56.95 Million USD | 98.566% |
LENSAR, Inc. | 1.75 Million USD | 53.314% |
Apyx Medical Corporation | 33.18 Million USD | 97.538% |
Cutera, Inc. | 418.69 Million USD | 99.805% |
STRATA Skin Sciences, Inc. | 15.04 Million USD | 94.569% |
BioSig Technologies, Inc. | 103 Thousand USD | -693.204% |
Anika Therapeutics, Inc. | 26.9 Million USD | 96.963% |
ClearPoint Neuro, Inc. | 9.94 Million USD | 91.788% |
Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 99.945% |
Axonics, Inc. | 25.84 Million USD | 96.838% |
Outset Medical, Inc. | 134.59 Million USD | 99.393% |
IRIDEX Corporation | 1.75 Million USD | 53.341% |
PROCEPT BioRobotics Corporation | 51.33 Million USD | 98.409% |
IRadimed Corporation | 1.61 Million USD | 49.414% |
Tivic Health Systems, Inc. | 176 Thousand USD | -364.205% |
INVO Bioscience, Inc. | 6.77 Million USD | 87.943% |
Telesis Bio, Inc. | 5.26 Million USD | 84.494% |
Viemed Healthcare, Inc. | 5.97 Million USD | 86.318% |
Varex Imaging Corporation | 464.2 Million USD | 99.824% |
Quipt Home Medical Corp. | 60.82 Million USD | 98.657% |
Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -38.946% |
Pulmonx Corporation | 35.08 Million USD | 97.672% |
Dynatronics Corporation | 3.25 Million USD | 74.927% |
ReShape Lifesciences Inc. | 151 Thousand USD | -441.06% |
Semler Scientific, Inc. | 70 Thousand USD | -1067.143% |
InMode Ltd. | 6.61 Million USD | 87.646% |
Bruker Corporation | 1.14 Billion USD | 99.929% |
Cytosorbents Corporation | 2.54 Million USD | 67.871% |
DexCom, Inc. | 2.57 Billion USD | 99.968% |
Align Technology, Inc. | 96.96 Million USD | 99.157% |
Viveve Medical, Inc. | 5.12 Million USD | 84.055% |
ZimVie Inc. | 508.79 Million USD | 99.839% |
Movano Inc. | 15.00 USD | -5446566.667% |
Cytek Biosciences, Inc. | 18.12 Million USD | 95.492% |
Nexalin Technology, Inc. | - USD | -Infinity% |
DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
Tandem Diabetes Care, Inc. | 398.6 Million USD | 99.795% |
Profound Medical Corp. | 4.97 Million USD | 83.576% |
Insulet Corporation | 1.36 Billion USD | 99.94% |
enVVeno Medical Corporation | 1.06 Million USD | 23.214% |
Surmodics, Inc. | 29.4 Million USD | 97.222% |
iCAD, Inc. | 273 Thousand USD | -199.267% |
Nuwellis, Inc. | 221 Thousand USD | -269.683% |
Biotricity, Inc. | 10.85 Million USD | 92.474% |
iRhythm Technologies, Inc. | 34.95 Million USD | 97.662% |
Aethlon Medical, Inc. | 649.75 Thousand USD | -25.74% |
InspireMD, Inc. | 1.03 Million USD | 21.291% |
PAVmed Inc. | 2.96 Million USD | 72.399% |
BIOLASE, Inc. | 13.98 Million USD | 94.158% |
Beyond Air, Inc. | 14.72 Million USD | 94.45% |
FONAR Corporation | 37.92 Million USD | 97.846% |
AxoGen, Inc. | 46.6 Million USD | 98.247% |
Vivani Medical, Inc. | 19.31 Million USD | 95.77% |
Tactile Systems Technology, Inc. | 44.61 Million USD | 98.169% |
Inari Medical, Inc. | 30.35 Million USD | 97.309% |
UFP Technologies, Inc. | 28 Million USD | 97.082% |
QT Imaging Holdings, Inc. | - USD | -Infinity% |
Heart Test Laboratories, Inc. | 434.04 Thousand USD | -88.229% |
Tenon Medical, Inc. | 428 Thousand USD | -90.888% |
Autonomix Medical, Inc. Common Stock | 1 Million USD | 18.463% |
Co-Diagnostics, Inc. | 2.15 Million USD | 62.038% |
AdaptHealth Corp. | 2.09 Billion USD | 99.961% |
Sintx Technologies, Inc. | 3.68 Million USD | 77.841% |
NanoVibronix, Inc. | - USD | -Infinity% |
Quanterix Corporation | 37.22 Million USD | 97.805% |
Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -38.946% |
Sensus Healthcare, Inc. | 596 Thousand USD | -37.081% |
Pacific Biosciences of California, Inc. | 892.24 Million USD | 99.908% |
TransMedics Group, Inc. | 506.2 Million USD | 99.839% |
ReWalk Robotics Ltd. | 607 Thousand USD | -34.596% |
NeuroMetrix, Inc. | 92.48 Thousand USD | -783.386% |
Hyperfine, Inc. | 64 Thousand USD | -1176.563% |
Establishment Labs Holdings Inc. | 188.73 Million USD | 99.567% |
Biomerica, Inc. | 459 Thousand USD | -77.996% |
Bone Biologics Corporation | - USD | -Infinity% |
AVITA Medical, Inc. | 449.48 Thousand USD | -81.764% |
Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -330.029% |
Silk Road Medical, Inc | 75.62 Million USD | 98.92% |